135 related articles for article (PubMed ID: 8824360)
1. The relation between cancer incidence among relatives and the occurrence of multiple primary carcinomas following head and neck cancer.
Bongers V; Braakhuis BJ; Tobi H; Lubsen H; Snow GB
Cancer Epidemiol Biomarkers Prev; 1996 Aug; 5(8):595-8. PubMed ID: 8824360
[TBL] [Abstract][Full Text] [Related]
2. The impact of smoking status, disease stage, and index tumor site on second primary tumor incidence and tumor recurrence in the head and neck retinoid chemoprevention trial.
Khuri FR; Kim ES; Lee JJ; Winn RJ; Benner SE; Lippman SM; Fu KK; Cooper JS; Vokes EE; Chamberlain RM; Williams B; Pajak TF; Goepfert H; Hong WK
Cancer Epidemiol Biomarkers Prev; 2001 Aug; 10(8):823-9. PubMed ID: 11489748
[TBL] [Abstract][Full Text] [Related]
3. Diagnosis of second head and neck tumors in primary laryngeal SCC is an indicator of overall survival and not associated with poorer overall survival: a single centre study in 987 patients.
Farhadieh RD; Salardini A; Yang JL; Russell P; Smee R
J Surg Oncol; 2010 Jan; 101(1):72-7. PubMed ID: 19798688
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of glutathione S-transferase polymorphisms and mutagen sensitivity as risk factors for the development of second primary tumors in patients previously diagnosed with early-stage head and neck cancer.
Minard CG; Spitz MR; Wu X; Hong WK; Etzel CJ
Cancer; 2006 Jun; 106(12):2636-44. PubMed ID: 16703596
[TBL] [Abstract][Full Text] [Related]
5. Randomized phase III trial of low-dose isotretinoin for prevention of second primary tumors in stage I and II head and neck cancer patients.
Khuri FR; Lee JJ; Lippman SM; Kim ES; Cooper JS; Benner SE; Winn R; Pajak TF; Williams B; Shenouda G; Hodson I; Fu K; Shin DM; Vokes EE; Feng L; Goepfert H; Hong WK
J Natl Cancer Inst; 2006 Apr; 98(7):441-50. PubMed ID: 16595780
[TBL] [Abstract][Full Text] [Related]
6. Risk factors for developing a second upper aerodigestive cancer after radiotherapy with or without chemotherapy in patients with head-and-neck cancers: an exploratory outcomes analysis.
Taussky D; Rufibach K; Huguenin P; Allal AS
Int J Radiat Oncol Biol Phys; 2005 Jul; 62(3):684-9. PubMed ID: 15936546
[TBL] [Abstract][Full Text] [Related]
7. Non-smoking and non-drinking patients with head and neck squamous cell carcinoma: a distinct population.
Farshadpour F; Hordijk GJ; Koole R; Slootweg PJ
Oral Dis; 2007 Mar; 13(2):239-43. PubMed ID: 17305629
[TBL] [Abstract][Full Text] [Related]
8. [Second primary tumors in patients with carcinoma of the head and neck].
Herranz González-Botas J; Sarandeses García A; Martínez Vidal J; Vázquez Barro C; López Amado M
Acta Otorrinolaringol Esp; 2000 Mar; 51(2):149-53. PubMed ID: 10804117
[TBL] [Abstract][Full Text] [Related]
9. Mutagen sensitivity as a biomarker for second primary tumors after head and neck squamous cell carcinoma.
Cloos J; Leemans CR; van der Sterre ML; Kuik DJ; Snow GB; Braakhuis BJ
Cancer Epidemiol Biomarkers Prev; 2000 Jul; 9(7):713-7. PubMed ID: 10919742
[TBL] [Abstract][Full Text] [Related]
10. Prophylactic Oophorectomy: Reducing the U.S. Death Rate from Epithelial Ovarian Cancer. A Continuing Debate.
Piver MS
Oncologist; 1996; 1(5):326-330. PubMed ID: 10388011
[TBL] [Abstract][Full Text] [Related]
11. An assessment of risk factors for the development of a second primary malignancy in the head and neck.
Bhattacharyya N
Ear Nose Throat J; 2006 Feb; 85(2):121-5. PubMed ID: 16579204
[TBL] [Abstract][Full Text] [Related]
12. Overexpression of p53 in tumor-distant epithelia of head and neck cancer patients is associated with an increased incidence of second primary carcinoma.
Homann N; Nees M; Conradt C; Dietz A; Weidauer H; Maier H; Bosch FX
Clin Cancer Res; 2001 Feb; 7(2):290-6. PubMed ID: 11234882
[TBL] [Abstract][Full Text] [Related]
13. Second primary tumours after a squamous cell carcinoma of the oral cavity or oropharynx using the cumulative incidence method.
van der Haring IS; Schaapveld MS; Roodenburg JL; de Bock GH
Int J Oral Maxillofac Surg; 2009 Apr; 38(4):332-8. PubMed ID: 19196493
[TBL] [Abstract][Full Text] [Related]
14. [Analysis of risk factors in the prediction of distant metastases of head and neck squamous cell carcinomas].
Li XM; Di B; Shang YD; Zhou YQ; Ma HM; Cheng JM
Zhonghua Er Bi Yan Hou Ke Za Zhi; 2004 Mar; 39(3):171-5. PubMed ID: 15283298
[TBL] [Abstract][Full Text] [Related]
15. Influence of the persistence of tobacco and alcohol use in the appearance of second neoplasm in patients with a head and neck cancer. A case-control study.
León X; del Prado Venegas M; Orús C; López M; García J; Quer M
Cancer Causes Control; 2009 Jul; 20(5):645-52. PubMed ID: 19067191
[TBL] [Abstract][Full Text] [Related]
16. Risk factors in oral and oropharyngeal squamous cell carcinoma: a population-based case-control study in southern Sweden.
Rosenquist K
Swed Dent J Suppl; 2005; (179):1-66. PubMed ID: 16335030
[TBL] [Abstract][Full Text] [Related]
17. Delayed regional metastases, distant metastases, and second primary malignancies in squamous cell carcinomas of the larynx and hypopharynx.
Spector JG; Sessions DG; Haughey BH; Chao KS; Simpson J; El Mofty S; Perez CA
Laryngoscope; 2001 Jun; 111(6):1079-87. PubMed ID: 11404625
[TBL] [Abstract][Full Text] [Related]
18. Radiotherapy in larynx squamous cell carcinoma is not associated with an increased diagnosis of second primary tumours.
Farhadieh RD; Rees CG; Yang JL; Salardini A; Russell P; Smee R
Clin Oncol (R Coll Radiol); 2009 May; 21(4):315-9. PubMed ID: 19233627
[TBL] [Abstract][Full Text] [Related]
19. Clinicopathologic characteristics of head and neck squamous cell carcinoma in Puerto Ricans.
Busquets JM; García HA; Trinidad-Pinedo J; Baez A
P R Health Sci J; 2003 Sep; 22(3):259-64. PubMed ID: 14619452
[TBL] [Abstract][Full Text] [Related]
20. Second primary head and neck tumor risk in patients with cervical cancer--SEER data analysis.
Rose Ragin CC; Taioli E
Head Neck; 2008 Jan; 30(1):58-66. PubMed ID: 17657793
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]